Crinetics Pharmaceuticals Inc (CRNX)
50.59
+1.09
(+2.20%)
USD |
NASDAQ |
May 22, 16:00
50.59
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Assets (Quarterly): 978.15M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 978.15M |
December 31, 2023 | 635.35M |
September 30, 2023 | 641.54M |
June 30, 2023 | 293.25M |
March 31, 2023 | 314.01M |
December 31, 2022 | 352.18M |
September 30, 2022 | 384.88M |
June 30, 2022 | 421.73M |
March 31, 2022 | 333.29M |
December 31, 2021 | 351.02M |
September 30, 2021 | 209.36M |
June 30, 2021 | 216.93M |
March 31, 2021 | 163.55M |
Date | Value |
---|---|
December 31, 2020 | 183.44M |
September 30, 2020 | 200.32M |
June 30, 2020 | 217.12M |
March 31, 2020 | 123.88M |
December 31, 2019 | 130.38M |
September 30, 2019 | 142.51M |
June 30, 2019 | 155.15M |
March 31, 2019 | 166.76M |
December 31, 2018 | 171.42M |
September 30, 2018 | 176.68M |
June 30, 2018 | 74.70M |
March 31, 2018 | 76.33M |
December 31, 2017 | 15.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
123.88M
Minimum
Mar 2020
978.15M
Maximum
Mar 2024
322.40M
Average
255.19M
Median
Total Assets (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 646.68M |
Geron Corp | 482.07M |
Madrigal Pharmaceuticals Inc | 1.082B |
PTC Therapeutics Inc | 1.790B |
Syndax Pharmaceuticals Inc | 543.03M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 103.22M |
Shareholders Equity (Quarterly) | 874.93M |
Current Ratio | 17.72 |